|
11 |
Noninvasive characterization of hepatic lesions by means of glypican-3–directed PET/CT Scholtissek, Helen. - Augsburg : Universität Augsburg, 2025
|
|
|
12 |
Prophylactic and pre-emptive donor lymphocyte infusion in patients with acute myeloid leukemia and myelodysplastic syndrome: validation of current recommendations and proposal of a modified outcome assessment Velázquez, Giuliano Filippini. - Augsburg : Universität Augsburg, 2025
|
|
|
13 |
Reduction of neuronal activity mediated by blood-vessel regression in the adult brain Gao, Xiaofei. - Augsburg : Universität Augsburg, 2025
|
|
|
14 |
The WERA cancer center matrix: strategic management of patient access to precision oncology in a large and mostly rural area of Germany Krebs, Markus. - Würzburg : Universität Würzburg, 2025
|
|
|
15 |
Upfront fixed-duration treatment strategies for chronic lymphocytic leukemia in Arab populations: a position statement from the Gulf region Yassin, Mohamed A.. - Augsburg : Universität Augsburg, 2025
|
|
|
16 |
C-X-C motif chemokine receptor 4–directed scintigraphy of multiple myeloma using [99mTc]Tc-PentixaTec Enke, Johanna. - Augsburg : Universität Augsburg, 2024
|
|
|
17 |
Circulating tumor DNA for prediction of complete pathological response to neoadjuvant radiochemotherapy in locally advanced rectal cancer (NEORECT Trial) Mögele, Tatiana. - Augsburg : Universität Augsburg, 2024
|
|
|
18 |
Concept and feasibility of the Augsburg Longitudinal Plasma Study (ALPS) - a prospective trial for comprehensive liquid biopsy-based longitudinal monitoring of solid cancer patients Sommer, Sebastian. - Augsburg : Universität Augsburg, 2024
|
|
|
19 |
Disclosing tumor biology by means of molecular imaging in a patient with malignant melanoma and chronic lymphocytic leukemia Gäble, Alexander. - Augsburg : Universität Augsburg, 2024
|
|
|
20 |
First safety and efficacy data with the radiohybrid 177Lu-rhPSMA-10.1 for the treatment of metastatic prostate cancer Dierks, Alexander. - Augsburg : Universität Augsburg, 2024
|
|